Tiotropium Bromide
Overview
The Summary of Product Characteristics, along with the Patient Information Leaflet for Tiotropium Bromide from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. To contact Teva's Medical Information Service email: medinfo@tevauk.com or telephone: 0207 540 7117.
- Capsules
Date of preparation: April 2023
D: COB-GB-NP-00112 (V1.0) / T: COB-GB-NP-00102 (V1.0) / M: COB-GB-NP-00103 (V1.0)
Date of preparation: April 2023
D: COB-GB-00016 (V1.0) / T: COB-GB-00014 (V1.0) / M: COB-GB-00015 (V1.0)
Date of preparation: April 2023
D: COB-GB-NP-00104 (V1.0) / T: COB-GB-NP-00105 (V1.0) / M: COB-GB-NP-00106 (V1.0)